Clinical Trial Update: Plasmapheresis for Nephrogenic Fibrosing Dermopathy (NFD)/Nephrogenic Systemic Fibrosis (NSF) [Phase 4]

View source ↗

Summary

Phase 4 trial investigating plasmapheresis for nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrogenic Fibrosing Dermopathy
• Nephrogenic Systemic Fibrosis

Snippet

Sponsor: Loma Linda University | Conditions: Nephrogenic Fibrosing Dermopathy, Nephrogenic Systemic Fibrosis | Phase 4 | Status: TERMINATED